Overview

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

Status:
Terminated
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This study will assess long-term safety and tolerability of repeat dose diazepam nasal spray in adolescents and adults with cluster seizures, with a focus on potential local effects (changes in nasal mucosa, olfaction, and taste).
Phase:
Phase 2
Details
Lead Sponsor:
Acorda Therapeutics
Treatments:
Diazepam